Carlo Battistini
14Patents
5h-index
36Co-inventors
66Inventor score
Filing activity: Jun 4, 1980 → Apr 30, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5547941A | Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions | Chemistry; Metallurgy | 46 | Expired |
| US5849710A | Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors | Human Necessities | 27 | Expired |
| US5288704A | Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent | Human Necessities | 25 | Expired |
| US4631150A | Process for the preparation of penems | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4337248A | Paromomycin containing compounds and method of use | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5905149A | Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors | Human Necessities | 4 | Expired |
| US6147073A | Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors | Human Necessities | 3 | Expired |
| US5374626A | 5'-alkylphosphonylnucleosides as antivirals | Chemistry; Metallurgy | 2 | Expired |
| US4508649A | Process for preparing optically active penems | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5869514A | Terpenoidic derivatives useful as antitumor agents | Human Necessities | 2 | Expired |
| US5922750A | Terpenoidic derivatives useful as antitumor agents | Human Necessities | 1 | Expired |
| US6245742A | Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use | Chemistry; Metallurgy | 1 | Expired |
| US8399668B2 | Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides | Human Necessities | 1 | Active |
| US5302588A | Crystalline (5R,6S)-2-carbamoyloxymethyl-6-[(1R)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.